- Home
- HOG vs AAPG Comparison
HOG vs AAPG Comparison
Compare HOG & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HOG | AAPG |
|---|---|---|
| Founded | 1903 | 2009 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Motor Vehicles | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.7B |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | HOG | AAPG |
|---|---|---|
| Price | $20.46 | $26.24 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | $28.00 | ★ $48.50 |
| AVG Volume (30 Days) | ★ 2.9M | 4.1K |
| Earning Date | 02-04-2026 | 03-26-2026 |
| Dividend Yield | ★ 3.51% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.04 | N/A |
| Revenue | ★ $4,664,627,000.00 | $54,524,554.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.04 | $368.64 |
| P/E Ratio | $5.07 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $20.40 | $16.50 |
| 52 Week High | $31.25 | $48.45 |
Technical Indicators
Market Signals| Indicator | HOG | AAPG |
|---|---|---|
| Relative Strength Index (RSI) | 26.14 | 36.65 |
| Support Level | $20.51 | $25.80 |
| Resistance Level | $21.17 | $26.66 |
| Average True Range (ATR) | 0.52 | 0.86 |
| MACD | 0.03 | -0.20 |
| Stochastic Oscillator | 1.52 | 9.50 |
Price Performance
Historical ComparisonAbout HOG Harley-Davidson Inc.
Harley-Davidson is a leading global manufacturer of heavyweight motorcycles across the custom, cruising, and touring categories, as well as related merchandise, parts, and accessories. In recent years, the firm has expanded into the adventure touring market with its Pan America model and into electric with the LiveWire brand. Its captive finance arm, Harley-Davidson Financial Services, provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley captured around 37% of the heavyweight domestic market in 2024.
About AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.